Cart
sales@molnova.com
(R,1R)-Tenofovir amibufenamide
CAS No. 1571076-37-3
(R,1R)-Tenofovir amibufenamide( —— )
Catalog No. M35711 CAS No. 1571076-37-3
(R,1R)-Tenofovir amibufenamide ((R,1R)-HS-10234) is an orally administered Tenofovir prodrug with antiviral activity. Tenofovir is a nucleotide reverse transcriptase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 141 | In Stock |
|
| 5MG | 128 | In Stock |
|
| 10MG | 190 | In Stock |
|
| 25MG | 328 | In Stock |
|
| 50MG | 433 | In Stock |
|
| 100MG | 586 | In Stock |
|
| 200MG | 775 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(R,1R)-Tenofovir amibufenamide
-
NoteResearch use only, not for human use.
-
Brief Description(R,1R)-Tenofovir amibufenamide ((R,1R)-HS-10234) is an orally administered Tenofovir prodrug with antiviral activity. Tenofovir is a nucleotide reverse transcriptase inhibitor.
-
Description(R,1R)-Tenofovir amibufenamide ((R,1R)-HS-10234) can be used for the purifying a tenofovir prodrug. Tynofovir (tenofovir) is a nucleoside acids reverse transcriptase inhibitors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorAntiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1571076-37-3
-
Formula Weight490.49
-
Molecular FormulaC22H31N6O5P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 200 mg/mL (407.76 mM; Ultrasonic )
-
SMILESC([C@H](OCP(OC1=CC=CC=C1)(NC(C(OC(C)C)=O)(C)C)=O)C)N2C=3C(N=C2)=C(N)N=CN3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. FuRao Zhang, et al. Method for purifying a tenofovir prodrug. CN104558035A
molnova catalog
related products
-
Rociclovir PM
Rociclovir PM (2-[(2-aminopurin-9-yl)methoxy]propane-1,3-diol) is a compound with antiviral activity
-
15-Dicaffeoylquinic ...
15-Dicaffeoylquinic acid has neuroprotective and antioxidant effects it can inhibition of GSK3β as well as the modulation of Bcl-2/Bax.
-
EIDD-2749
EIDD-2749 (4'-FlU), a ribonucleoside analog, is an orally available RdRp inhibitor with spectroscopic antiviral activity that interrupts the replication of respiratory syncytial virus and SARS-CoV-2.
